Belgium is experiencing a surge in influenza cases as the respiratory illness season takes hold, prompting a significant increase in demand for flu vaccinations nationwide. As of December 19th, nearly 1.923 million doses have been administered, surpassing last year’s totals-a trend health officials attribute to increased accessibility through pharmacies and ongoing public health campaigns [[3]]. While vaccination rates are up, some pharmacies have reported temporary supply challenges, a situation officials say stems from the country’s vaccine distribution system and unexpectedly high demand [[1]].
Nearly 1.923 million flu vaccines had been administered in Belgium as of December 19th, exceeding last year’s numbers by over 100,000 doses.
This increase in flu vaccination rates comes as public health officials emphasize the importance of preventative measures during the respiratory illness season. In Wallonia alone, 481,132 vaccines were given, representing a 6.45% increase compared to the same period last year, according to Walloon Health Minister Yves Coppieters.
Coppieters addressed questions regarding vaccine shortages at some pharmacies during a parliamentary session on Wednesday. He explained that the current supply challenges are linked to Belgium’s distribution structure and a significant surge in demand this season. “The tension around flu vaccines is explained by the supply structure in Belgium and a strong increase in demand this season,” he said.
The vaccine ordering process, which takes place between January and March, is based on the previous year’s volumes and triggers production that begins in May after strain selection, with vaccines becoming available in the fall. “Account was taken of the quantity of vaccines delivered last year and the order was then amplified,” Coppieters added, while noting the positive trend in vaccination coverage.
The rise in coverage is “largely related to the expansion of vaccination in pharmacies, which has considerably improved accessibility,” with a 38% increase in vaccinations administered in pharmacies. This expanded access is a key factor in encouraging more people to get vaccinated and protect themselves and their communities from the flu.
